verified SJR 1,122 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · SAGE Publications Ltd

workspace_premium Q1 — Endocrinology, Diabetes and Metabolism lock Subscription

Diabetes and Vascular Disease Research

Diabetes and Vascular Disease Research is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism and Internal Medicine with an H index of 65. It has an SJR impact factor of 1,122 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,122.

ISSN: 1479-1641

Publisher: SAGE Publications Ltd

Category: Endocrinology, Diabetes and Metabolism

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,122 Q1

H-index 65

Acceptance rate pie_chart

29% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,122

H-index

Docs (year)

Docs 3y

106

Total refs

784

Cites 3y

366

Citable 3y

104

Cites/Doc 2y

2.96

Ref/Doc

34.09

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes

What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management

Downregulation of MicroRNA 29a/b exacerbated diabetic retinopathy by impairing the function of Muller cells via Forkhead box protein O4

Do different definitions modify the gender-specific associations of metabolic syndrome with cardiovascular risk factors?

Diabetic retinopathy: treatment and prevention

Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities

Diabetes alters cardiovascular responses to anaesthetic induction agents in STZ-diabetic rats

Detection of myocardial microvascular disease using contrast echocardiography during adenosine stress in type 2 diabetes mellitus: Prospective comparison with single-photon emission computed tomography

Decreased platelet aggregation by shear stress-stimulated endothelial cells in vitro: Description of a method and first results in diabetes

Coexistence of smoking and metabolic syndrome among middle-aged patients with diabetes in the UK: a cross-sectional analysis

Co-existence of risk and protective haplotypes of Calpain 10 gene to type 2 diabetes in the eastern Indian population

Clinical implications of the metabolic syndrome

SHOW MORE ARTICLES

Chronic heart failure: A missing component of the metabolic syndrome?

Aleglitazar, a dual peroxisome proliferator-activated receptor-a and - gamma agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia

Cardiovascular disease markers in type 2 diabetes: the effects of a moderate home-based exercise training programme

C-peptide as a risk factor of coronary artery disease in the general population

Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction

Bardoxolone: Augmenting the Yin in chronic kidney disease

Association of the T54 allele of the FABP2 gene with cardiovascular risk factors in obese Mexican subjects

Association of mitochondrial DNA haplogroups and vascular complications of diabetes mellitus: A population-based study

Association between transcription factor 7-like 2 rs7903146 polymorphism and diabetic retinopathy in type 2 diabetes mellitus: A meta-analysis

Arterial hypertension defeated? Attacked from another angle

Arterial elasticity in obese adolescents with clinical features of insulin resistance

Antioxidant effects of a grape seed extract in a rat model of diabetes mellitus

FAQs

Diabetes and Vascular Disease Research has an SJR of 1,122 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Diabetes and Vascular Disease Research is 29%.

Diabetes and Vascular Disease Research

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Diabetes and Vascular Disease Research?

What is the APC / publication cost?

What is the acceptance rate?